Posted Feb. 21, 2012 at 1:46 p.m.

Premium Lock Charlotte firm's Parkinson drug candidate is in trouble

Published: 2012-02-21 13:46:06
Updated: 2012-02-21 13:46:06

Chelsea Chelsea

The U.S. Food and Drug Administration reviewer for Northera has recommended the agency not approve the drug being developed by Chelsea Therapeutics....

Read More
Read More

Copyright 2014 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Scroll